FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 77 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $277,000 | +9.5% | 83,119 | -0.1% | 0.00% | – |
| Q3 2019 | $253,000 | +308.1% | 83,231 | +220.5% | 0.00% | – |
| Q2 2019 | $62,000 | -58.4% | 25,970 | -34.6% | 0.00% | – |
| Q1 2019 | $149,000 | +2.1% | 39,686 | -2.6% | 0.00% | – |
| Q4 2018 | $146,000 | +1.4% | 40,727 | +62.4% | 0.00% | – |
| Q3 2018 | $144,000 | -10.0% | 25,081 | -21.5% | 0.00% | – |
| Q2 2018 | $160,000 | -18.4% | 31,939 | -16.3% | 0.00% | – |
| Q1 2018 | $196,000 | -16.9% | 38,137 | -2.7% | 0.00% | – |
| Q4 2017 | $236,000 | -66.1% | 39,185 | -68.8% | 0.00% | – |
| Q3 2017 | $696,000 | +18.8% | 125,436 | -0.7% | 0.00% | – |
| Q2 2017 | $586,000 | -20.5% | 126,280 | -15.2% | 0.00% | – |
| Q1 2017 | $737,000 | +106.4% | 148,981 | +363.8% | 0.00% | – |
| Q4 2016 | $357,000 | +34.2% | 32,120 | +11.9% | 0.00% | – |
| Q3 2016 | $266,000 | -8.9% | 28,697 | -37.7% | 0.00% | – |
| Q2 2016 | $292,000 | +279.2% | 46,058 | +288.2% | 0.00% | – |
| Q1 2016 | $77,000 | -57.9% | 11,863 | -52.5% | 0.00% | – |
| Q3 2015 | $183,000 | -36.2% | 24,997 | -10.8% | 0.00% | – |
| Q2 2015 | $287,000 | – | 28,029 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|